The White House declined to comment on Pfizer's deal, but a spokesman told reporters in a briefing that Congress should take action to prevent more such transactions.
The U.S. Treasury Department last week unveiled new rules to clamp down on inversions, its second attempt to do so since a wave of deals peaked in September 2014. But the latest rules amounted to tweaks of existing law and will not impede the Pfizer-Allergan transaction, tax experts said.
14:48 Katy Perry Scores $25 MILLION for 'American Idol' Deal21
20:32 Colts sign third-round pick Basham to complete rookie class13
20:26 Chaffetz will leave Congress June 30; Gowdy favored as next House Oversight chairman26
17:43 Pence says Trump remains focused on policy priorities, including tax cuts22